The role of prolidase activity in the diagnosis of uremic bone disease

Renal Failure

Volumn 28, Issue 4, 2006, Pages 271-274

  Rifki Evrenkaya, T ^a   Murat Atasoyu, Enes ^a   Kara, Muammer ^a   Unver, Suat ^a   Gultepe, Mustafa ^a  

^a GATA HAYDARPASA TRAINING HOSPITAL   (Turkey)

Author keywords

Bone alkaline phosphatase; Dialysis; Prolidase; TRAP; Uremic bone disease

Indexed keywords

ALKALINE PHOSPHATASE BONE ISOENZYME; PROLINE DIPEPTIDASE;

ADULT; AGED; ARTICLE; BONE BIOPSY; BONE DISEASE; BONE METABOLISM; BONE TURNOVER; CHRONIC KIDNEY FAILURE; CLINICAL ARTICLE; DIAGNOSTIC VALUE; DIALYSIS; DISEASE MARKER; ENZYME ACTIVITY; FEMALE; HUMAN; KIDNEY FAILURE; MALE; PRIORITY JOURNAL; UREMIA; UREMIC BONE DISEASE;

ACID PHOSPHATASE; ADULT; AGED; AGED, 80 AND OVER; ALKALINE PHOSPHATASE; BIOLOGICAL MARKERS; BONE DISEASES; DIPEPTIDASES; FEMALE; HUMANS; ISOENZYMES; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; STATISTICS; STATISTICS, NONPARAMETRIC;

EID: 33745566712     PISSN: 0886022X     EISSN: 15256049     Source Type: Journal    
DOI: 10.1080/08860220600577726     Document Type: Article

References (19)

1. Akoglu E, Suleymanlar G. Chronic renal failure. In: Ilicin G, Biberoglu K, Suleymanlar G, Unal S, eds. Internal Medicine. Ankara: Gunes Publication; 2003:1298-1308.
2. Iyidogan YO, Gurdol F, Oner P. Assessment of serum prolidase activity as bone production-destruction index. J. Istanbul Medical School. 1999;62:2-7.
3. Arata J, Umemura S, Yamamoto Y, Hagiyama M, Nohara N. Prolidase deficiency: its dermatological manifestations and some additional biochemical studies. Arch. Dermatol. 1979;115:62-67.
4. Hui KS, Lajtha A. Prolidase activity in brain: comparison with other organs. J. Neurochem. 1978;30:321-327.
5. Zuyderhoudt FM, Brugman AM, Smit JJ, de Jong L. Plasma prolidase in the rat: no index of liver fibrosis. Clin. Chem. 1985;31:662.
6. Myara I. Effect of long preincubation on the two forms of human erythrocyte prolidase. Clin. Chim. Acta. 1987;170:263-270.
7. Urena P, De Vernejoul MC. Circulating biochemical markers of bone remodeling in uremic patients. Kidney Int. 1999; 55:2141-2156.
8. Urena P, Hruby M, Ferreira A, Ang K, de Vernejoul M. Plasma total versus bone alkaline phosphatase as marker of bone turnover in hemodialysis patients. J. Am. Soc. Nephrol. 1996;7:506-512.
9. Coen G, Ballanti P, Bonucci E, Calabria S, Centorrino M, Fassino V, Manni M, Mantella D, Mazzaferro S, Napoletano I, Sardella D, Taggi F. Bone markers in the diagnosis of low turnover osteodystrophy in hemodialysis patients. Nephrol. Dial. Transplant. 1998;13:2294-2302.
10. Urena P, Ferreira A, Kung V, Morieu C, Simon P, Ang K, Souberbielle J, Segre G, Drüeke T, de Vernejoul M. Serum pyridinoline as a specific marker of collagen breakdown and bone metabolism in hemodialysis patients. J. Bone Miner. Res. 1995;10:932-939.
11. Naik RB, Gosling P, Price CP. Comparative study of alkaline phosphatase isoenzymes, bone histology and skeletal radiography in dialysis bone disease. Br. Med. J. 1977;31:1307-1310.
12. Lau K, Orishi T, Wergedal J, Singer F, Baylink D. Characterization and assay of tartrate-resistant acid phosphatase activity in serum: potential use to assess bone resorption. Clin. Chem. 1987;33:458-462.
13. Couttenye MM, D'Haese PC, Deng JT, Van Hoof VO, Verpooten GA, De Broe ME. High prevalence of adynamic bone disease diagnosed by biochemical markers in a wide sample of European CAPD population. Nephrol. Dial. Transplant 1997;12:2144-2150.
14. Ek-Rylander B, Flores M, Wendel M, Heinegard D, Andersson G. Dephosphorylation of osteopontin and bone sialoprotein by osteoclastic tartrate-resistant acid phosphatase. J. Biol. Chem. 1994;269:14853-14856.
15. Lopez Gavilanes E, Gonzalez Parra E, de la Piedra C, Caramelo C, Rapado A. Clinical usefulness of serum carboxy-terminal propeptide of procollagen I and tartrate-resistant acid phosphatase determinations to evaluate bone turnover in patients with chronic renal failure. Miner. Electrolyte Metab. 1994;20:259-264.
16. Stepan JJ, Silinkova-Malkova E, Havranek T, Formankova J, Zichova M, Lachmanova J, Strakova M, Broulik P, Pacovsky V. Relationship of plasma tartrate resistant acid phosphatase to the bone isoenzyme of serum alkaline phosphatase in hyperparathyroidism. Clin. Chim. Acta. 1983; 133(30):189-200.
17. Quarles ED, Lobaugh B, Murphy G. Intact parathyroid hormone overestimates the presence and severity of parathyroid-mediated osseous abnormalities in uremia. J. Clin. Endocrinol. Metab. 1992;75:145-150.
18. Sherrard DJ, Baylink DJ, Wergedal JE, Maloney NA. Quantitative histological studies on the pathogenesis of uremic bone disease. J. Clin. Endocrinol. Metab. 1974;39:119-135.
19. Erbagci AB, Araz M, Erbagci A, Tarakcioglu M, Namiduru ES. Serum prolidase activity as a marker of osteoporosis in type 2 diabetes mellitus. Clin. Biochem. 2002;35:263-268. Erratum in: Clin. Biochem. 2003;36(8):667.